| Bioactivity | Lagociclovir valactate is a prodrug of Lagociclovir (HY-14844). Lagociclovir valactate is an orally active anti-HBV agent[1]. |
| Target | HBV |
| In Vivo | Lagociclovir valactate (20 or 60 mg/kg; p.o.; daily for 10 weeks) shows anti-woodchuck hepatitis virus (WHV) activity in woodchucks[1]. Animal Model: |
| Name | Lagociclovir valactate |
| CAS | 1001670-19-4 |
| Formula | C19H27FN6O6 |
| Molar Mass | 454.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Michalak TI, et al. Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B. Antimicrob Agents Chemother. 2009 Sep;53(9):3803-14. |
Lagociclovir valactate
CAS: 1001670-19-4 F: C19H27FN6O6 W: 454.45
Lagociclovir valactate is a prodrug of Lagociclovir (HY-14844). Lagociclovir valactate is an orally active anti-HBV agen
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.